On 2025-05-08, Prime Medicine, Inc. (PRME) announced earnings per share of $-0.40 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-0.32.
The next expected annoucement date for quarterly earnings is 2025-08-14, with an average estimated earnings per share of $-0.36 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-0.32 | $-0.40 |
| 2025-02-28 | 2024-12-31 | $-0.37 | $-0.31 |
| 2024-11-12 | 2024-09-30 | $-0.43 | $-0.44 |
| 2024-08-08 | 2024-06-30 | $-0.40 | $-0.46 |
| 2024-05-10 | 2024-03-31 | $-0.45 | $-0.44 |
| 2024-03-01 | 2023-12-31 | $-0.48 | $-0.56 |
| 2023-11-03 | 2023-09-30 | $-0.45 | $-0.55 |
| 2023-08-07 | 2023-06-30 | $-0.42 | $-0.47 |
| 2023-05-11 | 2023-03-31 | $-0.42 | $-0.44 |
| 2023-03-09 | 2022-12-31 | $-0.77 | $-0.56 |